Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
714 INR | +0.02% | -4.70% | -10.66% |
05-01 | Rossari Biotech's Consolidated Profit Climbs in FIscal Q4 | MT |
04-30 | Transcript : Rossari Biotech Limited, Q4 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 | 18.31B 219M 300M | Sales 2025 * | 20.91B 251M 343M | Capitalization | 39.45B 473M 647M |
---|---|---|---|---|---|
Net income 2024 | 1.31B 15.67M 21.44M | Net income 2025 * | 1.64B 19.72M 26.98M | EV / Sales 2024 | 2.04 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 |
28.7
x | P/E ratio 2025 * |
24
x | Employees | 500 |
Yield 2024 * |
0.43% | Yield 2025 * |
0.36% | Free-Float | 31.68% |
Latest transcript on Rossari Biotech Limited
1 day | +0.02% | ||
1 week | -4.70% | ||
Current month | -4.70% | ||
1 month | +0.29% | ||
3 months | -6.31% | ||
6 months | -0.45% | ||
Current year | -10.66% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 58 | 96-12-31 | |
Edward Menezes
FOU | Founder | 63 | 96-12-31 |
Ketan Sablok
DFI | Director of Finance/CFO | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 50 | 23-04-28 | |
Edward Menezes
FOU | Founder | 63 | 96-12-31 |
Founder | 58 | 96-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 714 | +0.02% | 48 875 |
24-05-08 | 713.8 | -1.25% | 40,389 |
24-05-07 | 722.9 | -0.94% | 56,153 |
24-05-06 | 729.8 | +0.32% | 174,600 |
24-05-03 | 727.4 | -0.78% | 113,908 |
Delayed Quote NSE India S.E., May 09, 2024 at 07:43 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.66% | 473M | |
+17.60% | 66.6B | |
+0.84% | 48.75B | |
+17.11% | 41.45B | |
+22.26% | 26.74B | |
+11.45% | 19.55B | |
+4.76% | 18.21B | |
-21.31% | 16.02B | |
+3.82% | 15.62B | |
-7.54% | 15.33B |
- Stock Market
- Equities
- ROSSARI Stock